Overview

Formed in 2008, Neovasc Inc. is a specialty medical device company that develops, manufactures, and markets products for the rapidly growing cardiovascular marketplace.

Its products include the Tiara™ technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer™ for the treatment of refractory angina.

To receive Neovasc news updates Register Now

News

MORE

Presentations/ Events

MORE

Stock Chart

MORE

Financial Reports

MORE

Board Governance

MORE

Share Information

MORE

Stock Quote

PREVIOUS CLOSE

CHANGE 

% CHANGE 

INTRADAY HIGH 

INTRADAY LOW 

TSX:NVCN 

VOLUME 

TODAY’S OPEN 

Last updated: . Pricing delayed 20 minutes